⌘K

Atara Biotherapeutics, Inc. (ATRA)

$9.47 -5.30% $-0.53 Healthcare

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA368 program for patients with human papillomavirus associated cancers. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Market cap

$46.55M

CEO

Dr. Pascal Touchon D.V.M.

Full time employees

340.00

Headquarters

South San Francisco, CA

IPO Date

Oct 16, 2014

Price-to-earnings (PE) Ratio

-0.24

Earnings-per-share (EPS)

$-39.00

Cash ratio (TTM)

0.21

Current ratio (TTM)

0.42

Net profit margin (TTM)

-2,902.01%

PE ratio (TTM)

-0.34

PEG ratio (TTM)

-0.10

Price-to-book ratio (TTM)

-5.54

Price-to-sales ratio (TTM)

0.79

Quick ratio (TTM)

0.29

Return on assets (TTM)

-1,543.67%

Return on equity (TTM)

2,015.87%

Similar stocks (15)

Apellis Pharmaceuticals, Inc.

APLS

$41.05 4.48% $1.76

Downtrend

Arcus Biosciences, Inc.

RCUS

$15.72 -2.66% $-0.43

Downtrend

Sana Biotechnology, Inc.

SANA

$5.04 -6.84% $-0.37

Downtrend

iTeos Therapeutics, Inc.

ITOS

$14.80 -4.52% $-0.70

Neutral

Allogene Therapeutics, Inc.

ALLO

$2.41 -3.98% $-0.10

Downtrend

Fate Therapeutics, Inc.

FATE

$3.39 -4.51% $-0.16

Downtrend

TScan Therapeutics, Inc.

TCRX

$5.55 -1.42% $-0.08

Downtrend

Heron Therapeutics, Inc.

HRTX

$1.80 0.00% $0.00

Downtrend

HOOKIPA Pharma Inc.

HOOK

$4.74 -7.24% $-0.37

Downtrend

Caribou Biosciences, Inc.

CRBU

$1.72 -6.01% $-0.11

Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.22 -2.20% $-0.05

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.65 -3.51% $-0.02

Downtrend

Karyopharm Therapeutics Inc.

KPTI

$0.73 -8.46% $-0.07

Downtrend

BioXcel Therapeutics, Inc.

BTAI

$0.55 -7.41% $-0.04

Downtrend

Galera Therapeutics, Inc.

GRTX

$0.07 -0.13% $-0.00

Downtrend

ETF Exposure (12)

Loncar Cancer Immunotherapy ETF

CNCR

3.3%

$14.18 -1.98% $-0.29

Downtrend

Schwab U.S. Small-Cap ETF

SCHA

0.0010948217%

$48.38 -1.79% $-0.88

Neutral

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$48.18 -0.99% $-0.48

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$48.17 -0.99% $-0.48

Neutral

Vanguard Balanced Index Fund

VBINX

$48.17 -0.99% $-0.48

Neutral

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$129.08 -1.69% $-2.22

Neutral

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$92.34 -1.71% $-1.61

Neutral

Vanguard Institutional Total Stock Market Index Fund

VITPX

$92.32 -1.71% $-1.61

Neutral

Vanguard Total Stock Market Index Fund

VITSX

$129.67 -1.71% $-2.25

Neutral

Vanguard Total Stock Market Index Fund

VTI

$266.44 -1.66% $-4.50

Neutral

Vanguard Total Stock Market Index Fund

VTSAX

$129.65 -1.71% $-2.25

Neutral

Vanguard Extended Market Index Fund

VXF

$170.15 -1.70% $-2.94

Neutral

Downtrend

Similar stocks (15)

Apellis Pharmaceuticals, Inc.

APLS

$41.05 4.48% $1.76

Downtrend

Arcus Biosciences, Inc.

RCUS

$15.72 -2.66% $-0.43

Downtrend

Sana Biotechnology, Inc.

SANA

$5.04 -6.84% $-0.37

Downtrend

iTeos Therapeutics, Inc.

ITOS

$14.80 -4.52% $-0.70

Neutral

Allogene Therapeutics, Inc.

ALLO

$2.41 -3.98% $-0.10

Downtrend

Fate Therapeutics, Inc.

FATE

$3.39 -4.51% $-0.16

Downtrend

TScan Therapeutics, Inc.

TCRX

$5.55 -1.42% $-0.08

Downtrend

Heron Therapeutics, Inc.

HRTX

$1.80 0.00% $0.00

Downtrend

HOOKIPA Pharma Inc.

HOOK

$4.74 -7.24% $-0.37

Downtrend

Caribou Biosciences, Inc.

CRBU

$1.72 -6.01% $-0.11

Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.22 -2.20% $-0.05

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.65 -3.51% $-0.02

Downtrend

Karyopharm Therapeutics Inc.

KPTI

$0.73 -8.46% $-0.07

Downtrend

BioXcel Therapeutics, Inc.

BTAI

$0.55 -7.41% $-0.04

Downtrend

Galera Therapeutics, Inc.

GRTX

$0.07 -0.13% $-0.00

Downtrend

ETF Exposure (12)

Loncar Cancer Immunotherapy ETF

CNCR

3.3%

$14.18 -1.98% $-0.29

Downtrend

Schwab U.S. Small-Cap ETF

SCHA

0.0010948217%

$48.38 -1.79% $-0.88

Neutral

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$48.18 -0.99% $-0.48

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$48.17 -0.99% $-0.48

Neutral

Vanguard Balanced Index Fund

VBINX

$48.17 -0.99% $-0.48

Neutral

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$129.08 -1.69% $-2.22

Neutral

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$92.34 -1.71% $-1.61

Neutral

Vanguard Institutional Total Stock Market Index Fund

VITPX

$92.32 -1.71% $-1.61

Neutral

Vanguard Total Stock Market Index Fund

VITSX

$129.67 -1.71% $-2.25

Neutral

Vanguard Total Stock Market Index Fund

VTI

$266.44 -1.66% $-4.50

Neutral

Vanguard Total Stock Market Index Fund

VTSAX

$129.65 -1.71% $-2.25

Neutral

Vanguard Extended Market Index Fund

VXF

$170.15 -1.70% $-2.94

Neutral